Postinduction carbamazepine clearance in an adult psychiatric population
- PMID: 1923910
Postinduction carbamazepine clearance in an adult psychiatric population
Abstract
The objective of this study was to describe the postinduction clearance of carbamazepine (CBZ) in adult psychiatric patients by population pharmacokinetic analysis using the NONMEM program. Specifically, an estimate of CBZ clearance and insight into the effect of common patient characteristics on clearance were sought. Steady-state trough CBZ serum concentrations, CBZ dosing history, concomitant drug administration, and other data from 45 patients were collected retrospectively. A one-compartment model with first-order absorption and first-order elimination was used, with absorption rate, bioavailability, and volume of distribution fixed to literature values. No evidence was found that race, sex, age, ethanol use, smoking, and concomitant lithium significantly affected CBZ clearance. In the final model, clearance was based on lean body weight. The coefficient of variation for clearance estimates was 16.5%. Residual variability was modest. Estimates for volume of distribution, rates of absorption and elimination, and bioavailability could not be pursued rigorously. Although these results may assist in understanding CBZ disposition in this population, their general clinical application should be approached with caution.
Similar articles
-
Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.Methods Find Exp Clin Pharmacol. 2008 Nov;30(9):707-13. doi: 10.1358/mf.2008.30.9.1303589. Methods Find Exp Clin Pharmacol. 2008. PMID: 19229380
-
Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.Methods Find Exp Clin Pharmacol. 2007 Dec;29(10):673-9. doi: 10.1358/mf.2007.29.10.1116313. Methods Find Exp Clin Pharmacol. 2007. PMID: 18200330
-
Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.J Clin Pharm Ther. 2012 Jun;37(3):352-5. doi: 10.1111/j.1365-2710.2011.01296.x. Epub 2011 Aug 23. J Clin Pharm Ther. 2012. PMID: 21883329
-
[Population pharmacokinetics of carbamazepine in adults with epilepsy].Rev Invest Clin. 2005 Jan-Feb;57(1):38-48. Rev Invest Clin. 2005. PMID: 15981957 Spanish.
-
Population pharmacokinetics of lithium.Clin Pharm. 1991 May;10(5):376-81. Clin Pharm. 1991. PMID: 2049899
Cited by
-
Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.J Clin Pharmacol. 2013 Mar;53(3):276-84. doi: 10.1002/jcph.8. Epub 2013 Feb 13. J Clin Pharmacol. 2013. PMID: 23408495 Free PMC article. Clinical Trial.
-
Lean body mass as a predictor of drug dosage. Implications for drug therapy.Clin Pharmacokinet. 1994 Apr;26(4):292-307. doi: 10.2165/00003088-199426040-00005. Clin Pharmacokinet. 1994. PMID: 8013162 Review.
-
Inherent correlation between dose and clearance in therapeutic drug monitoring settings: possible misinterpretation in population pharmacokinetic analyses.J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):703-18. doi: 10.1007/s10928-005-0083-6. J Pharmacokinet Pharmacodyn. 2005. PMID: 16328100
-
Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.J Pharmacokinet Biopharm. 1994 Apr;22(2):165-77. doi: 10.1007/BF02353542. J Pharmacokinet Biopharm. 1994. PMID: 7815312
-
Population pharmacokinetics of carbamazepine in Singapore epileptic patients.Br J Clin Pharmacol. 2001 Jun;51(6):567-76. doi: 10.1046/j.0306-5251.2001.01396.x. Br J Clin Pharmacol. 2001. PMID: 11422016 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources